HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITY

This publication has 13 references indexed in Scilit:

• Increased Frequency of HLA-DRw3 in Systemic Lupus Erythematosus
  New England Journal of Medicine, 1979
• INCREASED FREQUENCY OF HLA-DRW2 IN SLE
  The Lancet, 1979
• Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.
  BMJ, 1978
• B-Lymphocyte Alloantigens Associated with Systemic Lupus Erythematosus
  New England Journal of Medicine, 1978
• Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis
  New England Journal of Medicine, 1978
• Disease and Acetylation Polymorphism
  Clinical Pharmacokinetics, 1977
• The determination of the acetylator phenotype of tuberculosis patients in czechoslovakia using sulhpadimidine
  Tubercle, 1973
• Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis
  The American Journal of Medicine, 1973
• Immune Responses to Hydralazine and Nuclear Antigens in Hydralazine-Induced Lupus Erythematosus
  Annals of Internal Medicine, 1972
• GENETIC VARIATIONS IN THE ACETYLATION OF ISONIAZID AND OTHER DRUGS
  Annals of the New York Academy of Sciences, 1968